Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Assmann

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Expert Review of Cardiovascular Therapy|November 19, 2005
Current understanding of the role of high-density lipoproteins in atherosclerosis and senescenceJerzy-Roch Nofer, Michael Walter, Gerd Assmann
Endocrinology and Metabolism Clinics of North America|May 26, 2004
Cardiovascular risk assessment in metabolic syndrome: view from PROCAMGerd Assmann, Jerzy-Roch Nofer, Helmut Schulte
International Journal of Epidemiology|January 24, 2003
Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Münster Study (PROCAM) using neural networksReinhard Voss, Paul Cullen, Helmut Schulte, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 21, 2007
Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM studyGerd Assmann, Paul Cullen, Frank Kannenberg, et al.
European Heart Journal|November 14, 2003
Response to Conroy et al. SCORE ProjectGerd Assmann, Paul Cullen, Helmut Schulte, et al.
Current Opinion in Lipidology|July 4, 2003
Inflammation in atherosclerosis, not yet time for a paradigm shift?Paul Cullen, Stefan Lorkowski, Helmut Schulte, et al.
European Heart Journal|September 6, 2005
Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAMGerd Assmann, Paul Cullen, Thomas Evers, et al.
Current Medical Research and Opinion|November 10, 2010
Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory careKurt Bestehorn, Wenefrieda Smolka, David Pittrow, et al.
European Heart Journal|April 26, 2003
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohortsHans-Werner Hense, Helmut Schulte, Hannelore Löwel, et al.
Biochemical and Biophysical Research Communications|December 29, 2005
Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinaseJerzy-Roch Nofer, Christian Noll, Renata Feuerborn, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Expert Review of Cardiovascular Therapy|November 19, 2005
Current understanding of the role of high-density lipoproteins in atherosclerosis and senescenceJerzy-Roch Nofer, Michael Walter, Gerd Assmann
Endocrinology and Metabolism Clinics of North America|May 26, 2004
Cardiovascular risk assessment in metabolic syndrome: view from PROCAMGerd Assmann, Jerzy-Roch Nofer, Helmut Schulte
International Journal of Epidemiology|January 24, 2003
Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Münster Study (PROCAM) using neural networksReinhard Voss, Paul Cullen, Helmut Schulte, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 21, 2007
Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM studyGerd Assmann, Paul Cullen, Frank Kannenberg, et al.
European Heart Journal|November 14, 2003
Response to Conroy et al. SCORE ProjectGerd Assmann, Paul Cullen, Helmut Schulte, et al.
Current Opinion in Lipidology|July 4, 2003
Inflammation in atherosclerosis, not yet time for a paradigm shift?Paul Cullen, Stefan Lorkowski, Helmut Schulte, et al.
European Heart Journal|September 6, 2005
Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAMGerd Assmann, Paul Cullen, Thomas Evers, et al.
Current Medical Research and Opinion|November 10, 2010
Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory careKurt Bestehorn, Wenefrieda Smolka, David Pittrow, et al.
European Heart Journal|April 26, 2003
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohortsHans-Werner Hense, Helmut Schulte, Hannelore Löwel, et al.
Biochemical and Biophysical Research Communications|December 29, 2005
Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinaseJerzy-Roch Nofer, Christian Noll, Renata Feuerborn, et al.
Pageof 9